IQ-AI announces positive results in ongoing GaM study
IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF), through its subsidiary Imaging Biometrics, has reported encouraging interim results from a Phase 1 study on oral gallium...
Stay updated with breaking news from Christopher Chitambar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF), through its subsidiary Imaging Biometrics, has reported encouraging interim results from a Phase 1 study on oral gallium...
Investegate announcements from IQ-AI Limited, Final Results
New research has shown iron-like compound holds promise for treating patients with glioblastoma, an aggressive brain cancer.
A novel therapy studied at the Medical College of Wisconsin (MCW) Cancer Center has led to a clinical trial for the treatment of glioblastoma, a rare and aggressive form of brain cancer, yet the most common primary brain tumor in adults.
/PRNewswire/ -- A novel therapy studied at the Medical College of Wisconsin (MCW) Cancer Center has led to a clinical trial for the treatment of glioblastoma,...